We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Walker & Dunlop
WD
$1.53B
| $8.66M | ﹤0.01% |
103,432
-13,012
| -11% | -$1.33M |
|
|
RYZ
1552
Ryerson Holding Corp
RYZ
$1.46B
| $8.62M | ﹤0.01% |
334,821
+28,527
| +9% | +$759K |
|
1553
Domo
DOMO
$184M
| $8.6M | ﹤0.01% |
478,168
+12,322
| +3% | +$323K |
|
1554
NBT Bancorp
NBTB
$2.74B
| $8.6M | ﹤0.01% |
226,652
-22,753
| -9% | -$899K |
|
1555
KB Home
KBH
$3.59B
| $8.58M | ﹤0.01% |
330,999
+9,525
| +3% | +$286K |
|
|
MRSN
1556
DELISTED
Mersana Therapeutics
MRSN
| $8.58M | ﹤0.01% |
50,765
+33,092
| +187% | +$5.38M |
|
1557
Nordic American Tanker
NAT
$1.37B
| $8.57M | ﹤0.01% |
3,210,132
+2,535,052
| +376% | +$6.73M |
|
1558
Sunstone Hotel Investors
SHO
$2.06B
| $8.53M | ﹤0.01% |
905,446
-86,478
| -9% | -$935K |
|
1559
Codexis
CDXS
$158M
| $8.53M | ﹤0.01% |
1,406,777
+230,600
| +20% | +$1.85M |
|
1560
FormFactor
FORM
$9.17B
| $8.51M | ﹤0.01% |
339,856
-10,815
| -3% | -$351K |
|
|
SRCL
1561
DELISTED
Stericycle Inc
SRCL
| $8.5M | ﹤0.01% |
201,930
-42,682
| -17% | -$2.05M |
|
1562
American Eagle Outfitters
AEO
$3.01B
| $8.48M | ﹤0.01% |
871,866
-181,687
| -17% | -$2.11M |
|
|
B
1563
DELISTED
Barnes Group Inc.
B
| $8.48M | ﹤0.01% |
293,545
-24,367
| -8% | -$782K |
|
1564
Brinker International
EAT
$9.66B
| $8.47M | ﹤0.01% |
339,224
+2,376
| +0.7% | +$64.2K |
|
1565
Advanced Energy
AEIS
$13B
| $8.47M | ﹤0.01% |
109,401
-1,568
| -1% | -$135K |
|
1566
Leslie's
LESL
$11M
| $8.47M | ﹤0.01% |
28,780
-766
| -3% | -$230K |
|
1567
Ultragenyx Pharmaceutical
RARE
$2.55B
| $8.45M | ﹤0.01% |
204,157
+3,874
| +2% | +$199K |
|
1568
Werner Enterprises
WERN
$2.25B
| $8.41M | ﹤0.01% |
223,684
-126,634
| -36% | -$5.16M |
|
1569
Albany International
AIN
$1.78B
| $8.4M | ﹤0.01% |
106,542
-3,059
| -3% | -$263K |
|
1570
Grocery Outlet
GO
$980M
| $8.39M | ﹤0.01% |
252,142
-111,267
| -31% | -$4.52M |
|
1571
Hecla Mining
HL
$11.3B
| $8.39M | ﹤0.01% |
2,129,569
-32,774
| -2% | -$133K |
|
1572
Addus HomeCare
ADUS
$2.23B
| $8.39M | ﹤0.01% |
88,085
-11,106
| -11% | -$1.02M |
|
1573
DocGo
DCGO
$62.6M
| $8.37M | ﹤0.01% |
844,071
+608,096
| +258% | +$5.49M |
|
|
CNR
1574
Core Natural Resources Inc
CNR
$4.45B
| $8.36M | ﹤0.01% |
130,032
+9,184
| +8% | +$581K |
|
1575
Sociedad Química y Minera de Chile
SQM
$20.6B
| $8.36M | ﹤0.01% |
92,150
-152,204
| -62% | -$14.8M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.